• Info
  • Insider Ownership

Insider Trading & Ownership of Brian Corvese

Location
New York, NY
Summary
The estimated net worth of Brian Corvese is at least $631,212 dollars as of 06 Jan 2026. Brian Corvese is the Director of MiNK Therapeutics, Inc. and owns shares of MiNK Therapeutics, Inc. (INKT) stock worth about $555.1K. Brian Corvese is the Director of Protagenic Therapeutics, Inc.\new and owns shares of Protagenic Therapeutics, Inc.\new (PTIX) stock worth about $76.1K.
Signature
By: /s/ Austin Charette, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Brian Corvese and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Brian Corvese has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $631,212.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: MiNK Therapeutics, Inc. ($555,087).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Brian Corvese

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
INKT MiNK Therapeutics, Inc. Director $555,087 02 Jan 2026
PTIX, PTIXW Protagenic Therapeutics, Inc.\new Director $76,125 25 Mar 2024
AGEN AGENUS INC Director 17 Jun 2025

Insider Transactions Reported by Brian Corvese:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.